We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+12.96%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$231B
AUM Growth
+$33B
Cap. Flow
+$7.99B
Cap. Flow %
3.46%
Top 10 Hldgs %
20.51%
Holding
6,891
New
816
Increased
2,304
Reduced
2,388
Closed
883

Sector Composition

Rank Sector Weight
1 Technology 8.34%
2 Healthcare 6.09%
3 Financials 5%
4 Consumer Discretionary 4.53%
5 Industrials 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBK icon
6476
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
-5,450
Closed -$1.17M
VCEL icon
6477
CALL
Vericel Corp
VCEL
$2.19B
-50,000
Closed -$1.68M
VCIG icon
6478
VCI Global
VCIG
$132K
0
-$43K
VDC icon
6479
Vanguard Consumer Staples ETF
VDC
$7.98B
-1,175
Closed -$215K
VECO icon
6480
Veeco
VECO
$2.93B
-100,321
Closed -$2.82M
VERV
6481
DELISTED
Verve Therapeutics
VERV
-91,948
Closed -$1.22M
VFS icon
6482
PUT
VinFast Auto
VFS
$7.28B
-76,700
Closed -$959K
VGK icon
6483
Vanguard FTSE Europe ETF
VGK
$31.2B
-572,770
Closed -$33.2M
VGT icon
6484
Vanguard Information Technology ETF
VGT
$145B
-21,160
Closed -$1.1M
VKTX icon
6485
CALL
Viking Therapeutics
VKTX
$3.95B
-114,400
Closed -$1.27M
VKTX icon
6486
PUT
Viking Therapeutics
VKTX
$3.95B
-44,800
Closed -$496K
VLGEA icon
6487
Village Super Market
VLGEA
$653M
-48,046
Closed -$1.09M
VOO icon
6488
Vanguard S&P 500 ETF
VOO
$1.02T
-16,136
Closed -$6.34M
VPL icon
6489
Vanguard FTSE Pacific ETF
VPL
$8.55B
-10,168
Closed -$680K
VRCA icon
6490
Verrica Pharmaceuticals
VRCA
$82.8M
-2,832
Closed -$110K
VREX icon
6491
PUT
Varex Imaging
VREX
$780M
-20,000
Closed -$376K
VRNS icon
6492
CALL
Varonis Systems
VRNS
$4.74B
-150,000
Closed -$4.58M
VTEB icon
6493
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.8B
-32,389
Closed -$1.56M
VTGN icon
6494
VistaGen Therapeutics
VTGN
$10.8M
-16,870
Closed -$88.4K
VTOL icon
6495
Bristow Group
VTOL
$1.34B
-25,579
Closed -$721K
VTR icon
6496
CALL
Ventas
VTR
$47.7B
-100,000
Closed -$4.21M
VTVT icon
6497
vTv Therapeutics
VTVT
$132M
-265
Closed -$5.06K
VTYX
6498
CALL
DELISTED
Ventyx Biosciences
VTYX
-50,000
Closed -$1.74M
VYGR icon
6499
Voyager Therapeutics
VYGR
$209M
-11,085
Closed -$85.9K
VYM icon
6500
Vanguard High Dividend Yield ETF
VYM
$83.2B
-48,406
Closed -$5M

Similar funds

Israel Englander's Q4 2023 Portfolio in Review

As of Q4 2023, Israel Englander held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Israel Englander deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.

  • Israel Englander's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
  • Israel Englander's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
  • Israel Englander fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
  • Israel Englander's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
  • Israel Englander opened 816 new positions and closed 883 in Q4 2023.
  • Israel Englander's portfolio value rose 17% quarter-over-quarter to $231B.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.